New biologics for psoriasis and psoriatic arthritis
Rozenblit M, Lebwohl M. New biologics for psoriasis and psoriatic arthritis. Dermatologic Therapy 2009, 22: 56-60. PMID: 19222517, DOI: 10.1111/j.1529-8019.2008.01216.x.Peer-Reviewed Original ResearchMeSH KeywordsAntibodies, MonoclonalArthritis, PsoriaticBiological ProductsClinical Trials as TopicDrug Delivery SystemsHumansPrevalencePsoriasisTumor Necrosis Factor-alphaConceptsPsoriatic arthritisPhase II studyNew biologic therapiesPrevalence of psoriasisSymptoms of psoriasisAlpha monoclonal antibodyTumor necrosis factorHuman tumor necrosis factorCertolizumab pegolBiologic therapyII studyJoint destructionInterleukin-23Rheumatoid arthritisInterleukin-12Radiographic evaluationTreatment optionsAlpha antibodyClinical trialsNecrosis factorNew biologicsArthritisPsoriasisMonoclonal antibodiesAntibodies